CSS
CYTK icon

Cubist Systematic Strategies’s Cytokinetics CYTK Stock Holding History

Cubist Systematic Strategies’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-48,604
Closed -$2.93M – 3191
2024
Q1 		$3.41M Sell
48,604
-37,459
-44% -$2.9M 0.02% 1235
2023
Q4 		$7.19M Buy
+86,063
New +$3.12M 0.05% 645
2023
Q1 		– Sell
-594
Closed -$27.2K – 3998
2022
Q4 		$27.2K Sell
594
-8,896
-94% -$383K ﹤0.01% 3970
2022
Q3 		$460K Sell
9,490
-7,333
-44% -$353K ﹤0.01% 3229
2022
Q2 		$661K Buy
16,823
+13,196
+364% +$531K ﹤0.01% 2830
2022
Q1 		$134K Sell
3,627
-102,224
-97% -$3.63M ﹤0.01% 3158
2021
Q4 		$4.83M Buy
105,851
+50,327
+91% +$1.94M 0.05% 680
2021
Q3 		$1.98M Buy
55,524
+10,905
+24% +$321K 0.03% 1027
2021
Q2 		$883K Sell
44,619
-37,016
-45% -$869K 0.01% 1668
2021
Q1 		$1.9M Buy
81,635
+71,714
+723% +$1.53M 0.02% 1074
2020
Q4 		$206K Sell
9,921
-5,833
-37% -$107K ﹤0.01% 2223
2020
Q3 		$341K Sell
15,754
-35,927
-70% -$840K 0.01% 1940
2020
Q2 		$1.22M Buy
51,681
+44,464
+616% +$834K 0.02% 1074
2020
Q1 		$85K Buy
7,217
+4,119
+133% +$52.6K ﹤0.01% 1933
2019
Q4 		$33K Sell
3,098
-13,419
-81% -$138K ﹤0.01% 2308
2019
Q3 		$188K Sell
16,517
-14,417
-47% -$181K ﹤0.01% 1798
2019
Q2 		$348K Buy
+30,934
New +$298K 0.01% 1701
2018
Q2 		– Sell
-10,163
Closed -$73K – 1839
2018
Q1 		$73K Buy
+10,163
New +$87.1K ﹤0.01% 1638

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cubist Systematic Strategies's CYTK Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of Cytokinetics (CYTK) in Q2 2024, closing a stake of 48,604 shares — an estimated $2.93M sold.

Cubist Systematic Strategies first reported a position in CYTK in Q1 2018 and held it in 18 quarters. The position peaked at $7.19M in Q4 2023. 343 funds tracked by Wall St. Rank hold CYTK as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining Cytokinetics position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 48,604 Cytokinetics shares in Q2 2024, an estimated $2.93M.
  • Cubist Systematic Strategies first reported a position in Cytokinetics in Q1 2018 and held it in 18 quarters.
  • Cubist Systematic Strategies's Cytokinetics position peaked at $7.19M in Q4 2023.
  • 343 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.